ACCESSWIRECore One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer’s and Parkinson's DiseaseRead full articleCore One Labs Inc.August 4, 2023 at 7:25 p.m.